Buy new:
-25% $21.13
Delivery Wednesday, July 17
Ships from: Amazon
Sold by: temex llc
$21.13 with 25 percent savings
List Price: $28.00

The List Price is the suggested retail price of a new product as provided by a manufacturer, supplier, or seller. Except for books, Amazon will display a List Price if the product was purchased by customers on Amazon or offered by other retailers at or above the List Price in at least the past 90 days. List prices may not necessarily reflect the product's prevailing market price.
Learn more
FREE International Returns
No Import Fees Deposit & $13.49 Shipping to France Details

Shipping & Fee Details

Price $21.13
AmazonGlobal Shipping $13.49
Estimated Import Fees Deposit $0.00
Total $34.62

Delivery Wednesday, July 17
Or fastest delivery Tuesday, July 16. Order within 15 hrs 36 mins
Only 1 left in stock - order soon.
$$21.13 () Includes selected options. Includes initial monthly payment and selected options. Details
Price
Subtotal
$$21.13
Subtotal
Initial payment breakdown
Shipping cost, delivery date, and order total (including tax) shown at checkout.
Ships from
Amazon
Ships from
Amazon
Sold by
Sold by
Returns
Eligible for Return, Refund or Replacement within 30 days of receipt
Eligible for Return, Refund or Replacement within 30 days of receipt
Returnable Yes
Resolutions Eligible for refund or replacement
Return Window 30 days from delivery
Refund Timelines Typically, an advance refund will be issued within 24 hours of a drop-off or pick-up. For returns that require physical verification, refund issuance may take up to 30 days after drop-off or pick up. Where an advance refund is issued, we will re-charge your payment method if we do not receive the correct item in original condition. See details here.
Late fee A late fee of 20% of the item price will apply if you complete the drop off or pick up after the ‘Return By Date’.
Restocking fee A restocking fee may apply if the item is not returned in original condition and original packaging, or is damaged or missing parts for reasons not due to Amazon or seller error. See details here.
Returns
Eligible for Return, Refund or Replacement within 30 days of receipt
Returnable Yes
Resolutions Eligible for refund or replacement
Return Window 30 days from delivery
Refund Timelines Typically, an advance refund will be issued within 24 hours of a drop-off or pick-up. For returns that require physical verification, refund issuance may take up to 30 days after drop-off or pick up. Where an advance refund is issued, we will re-charge your payment method if we do not receive the correct item in original condition. See details here.
Late fee A late fee of 20% of the item price will apply if you complete the drop off or pick up after the ‘Return By Date’.
Restocking fee A restocking fee may apply if the item is not returned in original condition and original packaging, or is damaged or missing parts for reasons not due to Amazon or seller error. See details here.

Return instructions

Item must be in original condition and packaging along with tag, accessories, manuals, and inserts. Unlock any electronic device, delete your account and remove all personal information.
Read full return policy
Payment
Secure transaction
Your transaction is secure
We work hard to protect your security and privacy. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others. Learn more
Payment
Secure transaction
We work hard to protect your security and privacy. Our payment security system encrypts your information during transmission. We don’t share your credit card details with third-party sellers, and we don’t sell your information to others. Learn more
$12.51
FREE International Returns
Minimal signs of wear. Corners and cover may show wear. May contain highlighting and or writing. May be missing dust jacket. May not include supplemental materials. May be a former library book. Ships direct from Amazon! Minimal signs of wear. Corners and cover may show wear. May contain highlighting and or writing. May be missing dust jacket. May not include supplemental materials. May be a former library book. Ships direct from Amazon! See less
Delivery Tuesday, July 16. Order within 16 hrs 21 mins
Only 1 left in stock - order soon.
$$21.13 () Includes selected options. Includes initial monthly payment and selected options. Details
Price
Subtotal
$$21.13
Subtotal
Initial payment breakdown
Shipping cost, delivery date, and order total (including tax) shown at checkout.
Access codes and supplements are not guaranteed with used items.
Added to

Sorry, there was a problem.

There was an error retrieving your Wish Lists. Please try again.

Sorry, there was a problem.

List unavailable.
Kindle app logo image

Download the free Kindle app and start reading Kindle books instantly on your smartphone, tablet, or computer - no Kindle device required.

Read instantly on your browser with Kindle for Web.

Using your mobile phone camera - scan the code below and download the Kindle app.

QR code to download the Kindle App

Follow the author

Something went wrong. Please try your request again later.

Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients Hardcover – February 5, 2013

4.5 4.5 out of 5 stars 1,071 ratings

{"desktop_buybox_group_1":[{"displayPrice":"$21.13","priceAmount":21.13,"currencySymbol":"$","integerValue":"21","decimalSeparator":".","fractionalValue":"13","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":true,"offerListingId":"ZS2Skj70GBCL04OPVJ73cXzlTSpqbIkYXh7aXTpxvLbHSXGOyTc4gCN2D2VGlKZR6snKDJPTq59%2BbLd8U2WvhBHKbc%2BfBhjkEgcERCeVbKwgx0c%2FkX18WYkGwFhQQAHNvKHZkRM71N%2FNwg8fZBBgox15HwCR7JynzgXEjUaxY2zIGZ5lpgKAYS31I0JG0r8t","locale":"en-US","buyingOptionType":"NEW","aapiBuyingOptionIndex":0}, {"displayPrice":"$12.51","priceAmount":12.51,"currencySymbol":"$","integerValue":"12","decimalSeparator":".","fractionalValue":"51","symbolPosition":"left","hasSpace":false,"showFractionalPartIfEmpty":true,"offerListingId":"ZS2Skj70GBCL04OPVJ73cXzlTSpqbIkYbH0czKaauu0jXmm6QAndfoNthTnhZ80OIh2e1xrRhvpv0m2Aba%2FulGEdqZcIFqUcDgI7Pi43WcCwFMF57PMIpppkyZp8IHuJNnFhfOIE%2Bz1BrNBMejmEN2L41UzsiuQi%2FzRo4IGEhPRrvHAUqh1iOQ%3D%3D","locale":"en-US","buyingOptionType":"USED","aapiBuyingOptionIndex":1}]}

Purchase options and add-ons

We like to imagine that medicine is based on evidence and the results of fair testing and clinical trials. In reality, those tests and trials are often profoundly flawed. We like to imagine that doctors who write prescriptions for everything from antidepressants to cancer drugs to heart medication are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators have some code of ethics and let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients.
All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct in the medical industry affects us on a global scale.
With Goldacre's characteristic flair and a forensic attention to detail,
Bad Pharma reveals a shockingly broken system and calls for regulation. This is the pharmaceutical industry as it has never been seen before.

Editorial Reviews

From Booklist

In the follow-up to his popular Bad Science (2010), British medical doctor Goldacre reveals how pharmaceutical companies mislead doctors and hurt patients. They “sponsor” trials, which tend to yield favorable results, while negative results often remain unreported. He also reports that drug companies spend twice as much on marketing and advertising as on researching and developing new drugs. Unfortunately for U.S. readers, he focuses largely on the UK, but ghost authorship of studies and “continuing medical education” boondoggle trips for doctors are problematic everywhere, and he does refer to the U.S. Food and Drug Administration on multiple occasions. And everyone, everywhere should feel unsettled by his discovery that pharmaceutical companies funnel $10 million to $20 million a year to such major medical journals as the New England Journal of Medicine and the Journal of the American Medical Association. Not surprisingly, he notes, studies funded by the pharmaceutical industry are that much more likely to get published in these influential journals. Goldacre’s essential exposé will prompt readers to ask more questions before automatically popping a doctor-prescribed pill. --Karen Springen

From Bookforum

Bad Pharma is surely the most comprehensive account to date of how the pharmaceutical industry games the regulatory process. Still, Bad Pharma is short on practical prescriptions for reform, and it is not until the last ten pages that Goldacre acknowledges that drug companies are manufacturing products that save lives and alleviate pain for billions of people. —Chris Wilson

Product details

  • Publisher ‏ : ‎ Farrar, Straus and Giroux; Reprint edition (February 5, 2013)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 448 pages
  • ISBN-10 ‏ : ‎ 0865478007
  • ISBN-13 ‏ : ‎ 978-0865478008
  • Item Weight ‏ : ‎ 1.25 pounds
  • Dimensions ‏ : ‎ 6 x 1.25 x 8.5 inches
  • Customer Reviews:
    4.5 4.5 out of 5 stars 1,071 ratings

About the author

Follow authors to get new release updates, plus improved recommendations.
Ben Goldacre
Brief content visible, double tap to read full content.
Full content visible, double tap to read brief content.

Discover more of the author’s books, see similar authors, read author blogs and more

Customer reviews

4.5 out of 5 stars
4.5 out of 5
1,071 global ratings

Customers say

Customers find the book very informative, thorough, and devastatingly clear indicting the perverse incentives of the drug industry. They also describe the book as compelling, clear, and absolutely necessary. Opinions are mixed on the content, with some finding it shocking and riveting, while others say it's not as interesting or scary as Bad Science.

AI-generated from the text of customer reviews

68 customers mention "Quality and value"64 positive4 negative

Customers find the book very informative, well-documented, and readable. They appreciate the statistical facts and wise, carefully thought-out thesis. Readers also appreciate the extensive list of references and thoroughness of the story. Overall, they say the book persuasively explains how pharmaceutical money, rather than unbiased clinical trials, largely influences the market.

"...And it is a very good reference for all the claims...." Read more

"...He is consistent throughout the book.4. Does a great job of explaining key medical terms, and provides a glossary of terms for quick..." Read more

"...He is careful to document and cite references...." Read more

"This is an incredibly deep and thorough look at the falsity and outright fraud being perpetrated through "scientific" studies and drug trials...." Read more

63 customers mention "Readability"59 positive4 negative

Customers find the book compelling, well written, and easy to understand. They also say it's an incredibly deep and thorough look at the falsity and outright.

"...The book is written in an easy to access language, and so it reads well...." Read more

"...In summary, a real eye-opening book worth reading. Doctor Goldacre exposes an industry that needs to be reformed for the well being of humanity...." Read more

"...His writing is direct, succinct, lively and engaging. He is careful to document and cite references...." Read more

"This is an incredibly deep and thorough look at the falsity and outright fraud being perpetrated through "scientific" studies and drug trials...." Read more

19 customers mention "Content"9 positive10 negative

Customers have mixed opinions about the content. Some find it shocking, riveting, and eye-opening, while others say it's not as interesting as Bad Science. They also say the subject and practices described are insidious, convoluted, and perverse.

"I've been a nurse for almost thirty years. There were very few surprises in the narrative; most of the problems the author discusses are well known..." Read more

"...The book is BORING...." Read more

"...Well-argued, credible, and supported by lots of research - and rather scary, frankly." Read more

"...and redundant, the same info could have been presented much more concisely and convincingly in half the space or less...." Read more

4 customers mention "Emotional tone"0 positive4 negative

Customers find the emotional tone of the book disturbing, depressing, and whiny. They also say the tone is breathless and dogmatic for their taste.

"...had to put it down several times before finishing it, disturbing and depressing and complicated as it made me feel...." Read more

"...The tone is a little breathless and dogmatic for my taste, and some points are oversold, but this book should be of interest to customers and to..." Read more

"Good points but too whiny. I prefer to read the same information from a more positive view." Read more

"A technical read -- interesting because it is so depressing...." Read more

Top reviews from the United States

Reviewed in the United States on September 19, 2016
Evidence based medicine is a term held near and dear, but evidence based research, studies etc. are not based on anything positive- all the so-called evidence is distorted in dozens of crucial stages including drug regulation and laws supposed to protect people.

1) New drugs are not needed, just more expensive and/ or replacements of less new dangerous drugs, or don't work well.
2) Data is purposely skewed to favor benefits. Bad trial data is lost or unreported.
3) Tests on humans are done in third world countries with less than ideal patients for the purpose of the drug
4) Regulators do not do their job as there is a big financial conflict of interest.
5) Doctors are either fooled or paid to push these drugs
6) Most doctors don't even know the difference between Relative Risk and Absolute Risk- big problem as this is the main way that drug's benefits are falsely increased and risks reduced- but it is all just distortion or statistics.

The big problem is that nobody in the industry wants to do anything about it. And if they try then they will be lambasted and thrown out of their medical society. We see the same thing happening with politics today- speak up and you are finished.

There are many more 'tricks of the trade' that are either deliberately used or become convenient loopholes in every stage of a drug's production and marketing that get used by scientists, regulators, academics and doctors either knowingly, knowingly with the acceptance of money or increased job status to further their interests.

Medical journals, for example are not published or edited by the serious scientific minds that we are led to believe- these magazines are either literally owned by the pharma companies themselves or bought with different forms of bribery.

The process from a drug's invention (usually a "me too" copy of a molecule) to it's marketing is filled with loopholes that have zero concern for the health or well being of the patient. In fact most drugs since the 1970s are only "invented" as a means to make more profit.

This book more than confirms my fears, doubts, and criticisms of medicine I've had my whole life, experienced and studied. And it is a very good reference for all the claims. As the author states, the main reason why people are so impressed and willing to be herded like cattle to slaughter when it comes to trusting medicine, is due to the fact that most people hate effort, especially when it comes to dry material and understanding statistics and systematic review. If it can't be explained in one sentence then most people are not interested.

The bottom line is that health is your main concern and drugs will never ultimately save you- only your diet and lifestyle can do that. Yet I am all too convinced that most people do not want to be helped- they just want to remain either helpless victims or they are just too stubborn to put the change and effort in to at least help their own situation, but becoming more aware of their own body and health,. Just like alternative medicine-another group of dubious individuals- people love to swallow a miracle pill and just let their faith guide them without ever gaining any genuine awareness of reality. That is fine with me- this is a free society to so what you please- just that the drug and supplement industry are not transparent, so that the majority of effortless people will unfortunately be misled and as a result suffer much harm, as we see with this health crisis.

At best we can look forward to the missing data becoming published in the public domain so that people can at least look at it. But few will do this. And, sadly, even IF the pharma system corrects the dozens of problems that mislead doctors and harm patients, most of the drugs that people take are based on the old system anyway.

I have little faith is any system, and am committed to helping people yes, but as Jesus said, "You have to save yourself".

2000 years later George Carlin added, "Ya gotta wanna"
6 people found this helpful
Report
Reviewed in the United States on October 15, 2012
Bad Pharma highlights serious issues with the way the pharmaceutical industry works today. In the book Ben highlights the problems with the industry from several angles, how the tests can be tweaked, how negative tests are not published, how you can make a neutral test appear positive by sub-dividing the goals and then emphasize the fluke positive one. He also shows how the medical journals are part of the problem and the issue with ghost written articles. He shows the problems with the regulatory side as well, for example the European Medicines Agency, their lack of transparency, and how they have effectively blocked access to critical data for researchers. All through the book Ben makes use of well documented examples, and all the issues highlighted are well documented and exemplified.

The book is written in an easy to access language, and so it reads well. He does repeat himself a bit, so one more round of editing and cleanup before release would probably have been a good idea. Some readers on amazon.co.uk have criticised this, but I don't see it as an issue.

You don't need to have a degree in medicine or a higher degree in general to understand the issues Ben highlights.

Ben Goldacre runs the Bad Science website (badscience dot net) and has previously written the book Bad Science. Where Bad Science was an attack on quackery and pseudo science, and his website to a large degree has dealt with the same topics, this book is a critical look at the pharmaceutical industry. As such it ought to silence those that have attacked Ben Goldacre for being in the pockets of the Pharmaceutical industry over time.

Ben Goldacre has done society a big favour by writing this book. I definitely recommend reading it if you want to understand more about how US and European health care works and what can be done to improve it in the future.
53 people found this helpful
Report

Top reviews from other countries

Translate all reviews to English
Elena
5.0 out of 5 stars Intense
Reviewed in Italy on June 27, 2019
A great book that gives numerous insights related to the effects of pharma industry on our everyday life.
One person found this helpful
Report
Kshitiz Goliya
5.0 out of 5 stars A scientific critique
Reviewed in India on August 7, 2017
I rarely give five stars but this book deserved it. While criticism can be ideological and philosophical, in this book it's based on scientific evidence. Drugs are all about science and decisions have to be made purely based on evidence. The author has tried to highlight the usual but hidden practices used by drugmakers to game the system. On the top of that, he tried to bring home the point that ignoring this directly affects people and poses threat to people's lives; even leading to death. He also focuses both on U.S. and Europe, thus improving our understanding of worldwide practices. The author's solution is clear: TRANSPARENCY. Regulators can't completely be relied upon on matters of life and death and we need more independent eyes to call out the fake data. This book is a must for every journalist as well as a doctor who rely on pharma companies to treat their patients.
3 people found this helpful
Report
Plinio José Cavalcante Monteiro
5.0 out of 5 stars Um livro fascinante!
Reviewed in Brazil on July 18, 2015
Completo e de linguagem acessível e atraente! Informações pertinentes e consistentes! Um livro que deveria ser lido por todo estudante de medicina!
2 people found this helpful
Report
WJD
5.0 out of 5 stars Give This Book to Your Doctor
Reviewed in Canada on April 30, 2013
After reading this magnificent work (you have to pay attention, that's for sure) I felt two things: (1)What a bunch of crooks and snake-oil hucksters the drug peddling industry is, and (2)how do I get this to my doctor without jeopardizing my standing with her. After all, this revelatory book should be read my every doctor whether or not they have a "No drug reps beyond this point" sign on the wall.

Way back when the FDA lowered by half (repeat: by half; i.e. by 50%!!) their estimate of how much blood cholesterol was dangerous and needed to be lowered with widespread use of statins, I became a thorough going skeptic of the FDA and the industry as a whole. Goldacre took a detailed look at the industry, the doctors who are (unknowingly, or unthinkingly, or otherwise) co-opted by pharmaceutical companies with big budgets, and the shoddy and sometimes intentionally misleading "studies" that purportedly prove the effectiveness of the drugs they are shilling to the unsuspecting public and the "look the other way" FDA and other agencies which are supposed to protect us from this charlatinism. Nobody comes out of this analysis clean and lilly white. Quite the opposite.

Goldacre is not a doomsayer, but he is certainly a whistle blower. Whether this has any effect on doctors in England, Europe, the States, or here in Canada is an open question. My gut feeling is: No, it will have little effect. But we patients might be able to have some influence. We can give our doctors this book and encourage them to read it. The tough job is to convince them that you are NOT inditing them by giving them the book. Many doctors are likely to take offense my your doing this. So... send it to them by mail with no (or a bogus) return address.

Even if 75% of what Goldacre says is wrong, it is still a big concern, and getting bigger. Everyone who cares about their health should read this, and then take extra precautions when doctors suggest drug treatments. Look more closely. It's up to us.
3 people found this helpful
Report
Oparazzo
5.0 out of 5 stars Follow the money
Reviewed in Germany on July 8, 2013
Mit "Bad Science" hatte Ben Goldacre 2009 das Licht der Literaturwelt erblickt. Damals hatte er vor allem Quacksalber, Pillendreher und sonstige Pseudowissenschaftler unterhaltsam aufs Korn genommen und eine Lanze für die evidenzbasierte Medizin gebrochen.

In "Bad Pharma" lernen wir nun, dass auch in dieser vieles, sehr vieles im Argen liegt. Ben Goldacre führt uns ein Gesundheitswesen vor, das von den Geschäftsinteressen der Pharmaindustrie gesteuert wird und das Wohl der Patienten weitgehend aus den Augen verloren hat. Hier einige Gründe für dieses Desaster:

Die medizinischen Testreihen, in denen neue Medikamente an Versuchspersonen und Patienten ausprobiert werden, werden ganz überwiegend von der Pharmaindustrie finanziert und kontrolliert. Das führt nicht nur dazu, dass systematischen und statistischen Manipulationen, die gewünschte Effekte übertreiben und unerwünschte Nebenwirkungen herunterspielen, Tür und Tor geöffnet wird, sondern dass ganze, für das betreffende Medikament weniger schmeichelhafte Testreihen überhaupt nicht veröffentlicht werden. Es fehlen daher die Erkenntnisse aus mindestens der Hälfte aller Untersuchungen, Erkenntnisse, für die Versuchspersonen und Patienten ihre Gesundheit, wenn nicht gar ihr Leben riskiert hatten.

Auch die Fachzeitschriften, in denen diese Testreihen veröffentlicht werden, sind finanziell von der Pharmaindustrie abhängig: Ein Unternehmen, dass teure Anzeigen schaltet, wird man tunlichst nicht mit Artikeln verprellen, die unschöne Nebenwirkungen eines seiner Superprodukte zum Thema haben. Und die Zeitschriften tolerieren weiterhin stillschweigend das Ghostwriterunwesen, bei dem die Koryphäen von den Unikliniken zu den veröffentlichten Artikeln kaum mehr als ihren Namen beitragen.

Für Marketing gibt die Pharmaindustrie etwa doppelt so viel aus wie für Forschung und Entwicklung. Dabei handelt es sich z. B. die "Weiterbildung" von Ärzten in 5-Sterne-Resorts an den schönsten Orten dieser Welt, aber auch um die Heerscharen von Pharmavertretern, die Ärzte mehr oder weniger nachdrücklich (und nachgewiesenermaßen sehr erfolgreich) von den Vorzügen ihres Sortiments überzeugen. Hier steht das Ziel der Industrie, ihre Produkte möglichst teuer zu verkaufen und ihren Aktionären Freude zu machen, in klarem Konflikt mit dem Interesse des Patienten, die beste Behandlung zu bekommen, und auch mit dem Interesse der Krankenkassen, das Geld der Versicherten nicht für neue, teurere Medikamente zu verschleudern, die nicht besser sind als die Generika, die sie ersetzen sollen.

Es gibt inzwischen in vielen Ländern halbherzige Ansätze, all diese Praktiken durch geeignete Regelungen zu einzudämmen, aber selbst diese werden von den zuständigen Behörden bisher kaum oder gar nicht nicht umgesetzt.

Das Beunruhigendste ist aber, dass praktisch alle Medikamente, die heute verschrieben werden, mit diesen höchst evidenzverfälschenden Methoden auf den Markt gebracht wurden. Es wäre für die Beteiligten also nicht damit getan, sich ab sofort ethisch und juristisch korrekt zu verhalten, sondern es muss alle Evidenz der Vergangenheit auf den Tisch, die jetzt noch unter Verschluss gehalten wird. Überhaupt ist "Bad Pharma" voller Vorschläge, wie Abhilfe geschaffen werden kann, und auch uns Lesern, ob wir nun Ärzte und Patienten oder Verantwortliche der Pharmaindustrie sind, gibt Goldacre zu jedem Thema konkrete Ratschläge, wie wir dazu beitragen können, diesen übelriechenden Sumpf trockenzulegen: Wenn wir nichts tun, werden sich "die da oben" nicht bewegen.

Für den leidlich informierten Leser ist nicht alles, was hier zusammengetragen wurde, neu und überraschend, aber als hervorragend recherchiertes und vorzüglich geschriebenes Kompendium für die Missstände bei Entwicklung und Anwendung von Medikamenten ist "Bad Pharma" wohl einzigartig. Ohnehin macht die Tatsache, dass so vieles allgemein bekannt ist, sich aber trotzdem kaum etwas ändert, alles eigentlich noch viel schlimmer.
4 people found this helpful
Report